您的位置:首页 > 与会专家 > 正文

Ronald W. Mink

更新时间:2016/10/17 22:57:16



       Ronald W. Mink博士,获伊利诺伊大学博士学位、俄亥俄州立大学微生物学学士和硕士学位,自2009年以来担任Sedia公司总裁和首席科学官,也是该公司创始人之一,董事会成员。
Mink博士自2009年在美国Sedia公司与美国CDC保持紧密合作,包括多次在全球艾滋病大会上担任美国CDC的顾问,落实和完善美国CDC的HIV-1亲和力检测技术、国际首发升级亲和力人群监测产品至单人份检测产品,多次获得美国最高奖项的新产品研发基金的支持。
Mink博士在美国克利普特生物制药公司从2001~2003年担任全职顾问,2003~2005年为研发总监,从2005年6月到2008年12月担任首席科学官(CSO)。他将POCT诊断测试技术引入到企业,建立了口腔黏膜渗出液诊断产品线,负责BED HIV-1发病率EIA 开发和扩大公司Aware? HIV产品线,并建立了新的生命科学部门。
他曾担任Orasure公司技术研发总监(公司纳斯达克股票代码:osur)。他曾持有口腔黏膜渗出液诊断检测的几项专利,包括OraQuick®HIV快速检测、第一个美国FDA批准的唾液HIV快速检测试剂和其它口腔疾病病原体检测试剂。
他还有在Eli Lilly 公司诊断组和Carter Wallace等公司工作的经验,一直致力于开发并使快速检测商业化,产品包括First Response®一步怀孕测试、First Response®排卵测试卡、CARDS QS® hCG、 CARDS OS® Strep B、POCT和OTC试验等。

Ronald W. Mink, Ph.D., Member of the Board Dr. Mink has served as President and Chief Science Officer of Sedia Biosciences since 2009 and is also a co-founder. Dr. Mink has been on the board since its founding. Previously, Dr. Mink served as Chief Science Officer (CSO) of Calypte Biosciences from June 2005 until December 2008 and as Director of R&D at Calypte from 2003 until 2005. He also served as a full time consultant for Calypte from 2001 to 2003. At Calypte, he introduced rapid point of care diagnostic testing technology to the company, established the oral fluid diagnostic product line, oversaw development of the BED HIV-1 Incidence EIA and expanded the company’s Aware? line of HIV products, and launched the creation of its new Life Sciences Division. Prior to Calypte, he was Director of R&D at OraSure Technologies, Inc. (NASDAQ: OSUR). Dr. Mink holds several patents for oral fluid diagnostic tests, including the OraQuick® HIV rapid test, the first U.S. FDA approved rapid oral fluid HIV test. and other tests for oral disease pathogens. He has prior experience successfully developing and commercializing rapid assays in such companies as Eli Lilly and Co.’s diagnostic group and Carter Wallace, culminating in the commercialization of several products including First Response® One Step Pregnancy Test, First Response® 3 Minute Ovulation Test, CARDS QS® hCG, CARDS OS® Strep B and other point-of-care and OTC tests. Dr. Mink received his Ph.D. in Microbiology from the University of Illinois and B.S. and M.S. from Ohio State University.
距离会议开幕还有
会议时间
2016年10月26-29日
征文投稿截止日期
2016年8月31日
网上注册截止日期
2016年10月7日
现场报到日期
2016年10月26日